Dataset from A Phase 2, Multicenter, Randomized Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer (AIPC) Following Disease Progression on Docetaxel-Based Chemotherapy
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009958
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether IMC-A12 or IMC-1121B (ramucirumab) with
Mitoxantrone and Prednisone is effective in the treatment of metastatic androgen- independent
prostate cancer (APIC).
创建时间：
2025-02-10
